Nationwide Children's News Releases

May 03, 2005

Columbus Children's Hospital Leads First National Muscular Dystrophy Newborn Screening Study

Columbus Children’s Research Institute (CCRI) at Columbus Children’s Hospital recently received a grant from the Centers for Disease Control to develop and implement a newborn screening trial for Duchenne muscular dystrophy, the most common type of muscular dystrophy in children.

Mar 16, 2005

New Program Encourages Kids to Make Healthier Lunch Choices

With government figures estimating 30 percent of all U.S. children are overweight or at risk for being too heavy, there is a necessity for innovative new strategies to prevent these young people from becoming overweight or obese adults.

Mar 11, 2004

Radiological Invention Will Improve Health Care for Children

Small patients normally do not fit into standard medical practice—young children are naturally active, making tasks as simple as performing an X-ray problematic for pediatric radiology professionals around the country.

Sep 04, 2002

CONJOINED TWINS SUCCESSFULLY SEPARATED

Twin girls born joined at the chest and abdomen are in critical condition and comfortably resting after surgery to separate them Friday, Aug. 30, at Columbus Children's Hospital.

Jan 01, 0001

PANERA’S INAUGURAL ‘CHIP IN FOR CHILDREN’S MENTAL HEALTH’ CAMPAIGN TO BENEFIT ON OUR SLEEVES MAY 9-22

Covelli Enterprises, the largest franchisee of Panera Bread, is partnering with On Our Sleeves, the movement for children’s mental health, through the launch of its inaugural Chip in for Children’s Mental Health campaign. In honor of Mental Health Awareness month, from May 9-22, a portion of proceeds from all Chocolate Chipper cookies sold at thirty-nine Covelli-owned and operated Panera Bread locations in Columbus and Central Ohio, will support this vital initiative, powered by Nationwide Children’s Hospital.

Jan 01, 0001

4-Year Study Finds No Correlation Between Head Impacts and Cognitive Outcomes in Youth Tackle Football Players

Dr. Sean Rose and colleagues collaborated with MORE Foundation, the Complex Concussion Clinic at Nationwide Children's, and other researchers to prospectively follow youth tackle football players in real time across four seasons, which can account for confounding factors. The study, recently published in JAMA Network Open, was conducted from July 2016 through January 2020, and enrolled players from four football teams. A total of 70 male players, 9-12 years of age, who were in 5th and 6th grade, volunteered to participate, with 18 completing all four years of the study.

Jan 01, 0001

Nationwide Children’s Hospital and Big Lots Announce 2022 Recipient of Big Lots Behavioral Health Scholarship

Christy Chacko, a graduate student at the University of Southern California, is the 2022 recipient of the Big Lots Behavioral Health Scholarship—a scholarship made possible by Nationwide Children’s Hospital and Big Lots, an Ohio-based home discount retailer.

Jan 01, 0001

Investigators Develop Technique to Effectively Edit NK Cells to Target Specific Cancer Cells

Originally, NK cells seemed promising for a natural therapy to fight cancer due to their innate ability to recognize any cells expressing stress or signs of infection. But investigators quickly realized they faced three key challenges: first, it was difficult to grow a large enough number of NK cells in the lab to offer useful infusions at a reasonable cost; second, an ideal universal donor solution was needed to make NK cell products faster, more reliably and with off-the-shelf availability; and third, NK cells were resistant to genetic modifications that might help them better target specific types of cancer cells. Nationwide Children’s Hospital investigators and their collaborators painstakingly solved the first two problems over the past decade. Now, they’ve conquered the third.

Jan 01, 0001

A Single-Dose Cancer Immunotherapy via Gene Transfer

Researchers at Nationwide Children’s Hospital report proof-of-principle results for a new gene therapy cancer treatment. The off-the-shelf, single-dose immunotherapy serves as an alternative to CAR-T therapy and can be engineered to be on-demand.

Jan 01, 0001

News Detail